N,N-bis(1-naphthyl)formamide | 1263068-93-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N,N-bis(1-naphthyl)formamide
• 英文别名: N,N-dinaphthalen-1-ylformamide
• CAS: 1263068-93-4
• 化学式: C₂₁H₁₅NO
• 分子量: 297.356
• InChiKey: LRWSZUSHEFGCQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N,N-bis(1-naphthyl)formamide 在 草酰氯 作用下， 以 二氯甲烷 为溶剂， 生成 dichloromethyl-di-(1-naphthyl)amine
  参考文献：
  名称：

  On the Formation and ¹H NMR-spectroscopic Characterization of N,N-Diaryl-substituted Formamide Chlorides

  摘要：

  N,N-二芳基取代甲酰胺与草酸氯酰发生反应，不会形成预期的盐类状甲酰胺氯化物，而是形成相应的非离子性N-二氯甲基取代的二芳胺。

  DOI：

  10.1515/znb-2012-0401
• 作为产物：
  描述：

  甲酸 、 1,1'-二萘胺 反应 6.0h， 生成 N,N-bis(1-naphthyl)formamide
  参考文献：
  名称：

  On the Formation and ¹H NMR-spectroscopic Characterization of N,N-Diaryl-substituted Formamide Chlorides

  摘要：

  N,N-二芳基取代甲酰胺与草酸氯酰发生反应，不会形成预期的盐类状甲酰胺氯化物，而是形成相应的非离子性N-二氯甲基取代的二芳胺。

  DOI：

  10.1515/znb-2012-0401

文献信息

• Fused ring compound and use thereof
  申请人：Suzuki Hideo

  公开号：US20100190747A1

  公开（公告）日：2010-07-29

  The present invention provides a compound represented by the formula: wherein the symbols are as described in the specification, or a salt thereof, which is useful for preventing/treating eicosanoid-associated diseases such as atherosclerosis, diabetes, obesity, atherothrombosis, asthma, fever, pain, cancer, rheumatism, osteoarthritis and atopic dermatitis, and which has an excellent pharmacological action, physicochemical properties, etc.

  本发明提供一种化合物，其化学式如下： 其中符号如规范中所述，或其盐，用于预防/治疗与前列腺素相关的疾病，如动脉粥样硬化、糖尿病、肥胖、动脉血栓形成、哮喘、发热、疼痛、癌症、风湿病、骨关节炎和特应性皮炎等，并具有优异的药理作用、理化性质等。
• CATALYST FOR ASYMMETRIC HYDROGENATION
  申请人：MAEDA Hironori

  公开号：US20100324338A1

  公开（公告）日：2010-12-23

  This invention aims at providing a catalyst for producing an optically active aldehyde or an optically active ketone, which is an optically active carbonyl compound, by carrying out selective asymmetric hydrogenation of an α,β-unsaturated carbonyl compound, particularly a catalyst which is insoluble in a reaction mixture for obtaining optically active citronellal which is useful as a flavor or fragrance, by carrying out selective asymmetric hydrogenation of citral, geranial or neral; and a method for producing a corresponding optically active carbonyl compound. The invention relates to a catalyst for asymmetric hydrogenation of an α,β-unsaturated carbonyl compound, which comprises a powder of at least one metal selected from metals belonging to Group 8 to Group 10 of the Periodic Table, or a metal-supported substance in which at least one metal selected from metals belonging to Group 8 to Group 10 of the Periodic Table is supported on a support, an optically active cyclic nitrogen-containing compound and an acid.

  这项发明旨在通过对α，β-不饱和羰基化合物进行选择性不对称加氢，特别是通过对柠檬醛、香叶醛或柠檬醛进行选择性不对称加氢，从而提供用作香料或香精的有用的光学活性香茅醛的催化剂，该香茅醛是一种光学活性羰基化合物；以及生产相应的光学活性羰基化合物的方法。该发明涉及一种用于不对称加氢α，β-不饱和羰基化合物的催化剂，其包括来自周期表第8至第10族金属中至少一种金属的粉末，或者至少一种来自周期表第8至第10族金属的金属负载物质，该金属负载在一种支撑物上，还包括光学活性的含氮环化合物和酸。
• HETEROCYCLIC COMPOUNDS
  申请人：Ishichi Yuji

  公开号：US20120088748A1

  公开（公告）日：2012-04-12

  Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I) wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.

  提供的是一种具有单胺再摄取抑制活性的化合物，其化学式表示为（I），其中环A是一个可选择取代的6元芳香环，环B是环A上的取代基可选择地与环A一起形成一个可选择取代的9或10元芳香融合环，其他符号如规范中定义的那样，或其盐。
• FUSED RING COMPOUND AND USE THEREOF
  申请人：Maekawa Tsuyoshi

  公开号：US20100197683A1

  公开（公告）日：2010-08-05

  Provided is a novel compound represented by the following formula Wherein each symbol is as defined in the specification, or a salt thereof, which has an angiotensin II receptor antagonistic activity and a peroxisome proliferator-activated receptor γ agonistic activity, and is useful as an agent for the prophylaxis or treatment of circulatory diseases such as hypertension and the like and/or metabolic diseases such as diabetes and the like, and the like.

  提供的是一种新化合物，其化学式如下所示。其中每个符号如规范中定义，或其盐，具有抗肾素II受体拮抗活性和过氧化物酶增殖激活受体γ激动活性，可用作预防或治疗循环疾病（如高血压等）和/或代谢疾病（如糖尿病等）的药物。
• STILBENE-BASED COMPOUND OR SALT THEREOF, AND POLARIZING FILM, POLARIZING PLATE, AND DISPLAY DEVICE
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：US20200157353A1

  公开（公告）日：2020-05-21

  The present disclosure is a stilbene-based compound or a salt thereof represented by a following formula (1), wherein a group X represents a nitro group or an amino group optionally having a substituent; a group Y represents an amide group optionally having a substituent or a naphthotriazole group optionally having a substituent; and p and q each independently represent an integer of 0 to 2.

  本公开涉及一种基于stilbene的化合物或其盐，其表示如下式（1），其中X代表一个硝基或一个氨基，可选地具有取代基；Y代表一个酰胺基，可选地具有取代基，或一个萘三唑基，可选地具有取代基；p和q各自独立地代表0到2的整数。